Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Antigonadotropin-Leuprolide in Alzheimer's Disease Drug INvestigation (ALADDIN) VP 104 Study

ClinicalTrials.gov ID: NCT00076440

Public ClinicalTrials.gov record NCT00076440. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 30, 2026, 6:25 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT00076440
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Voyager Pharmaceutical Corporation
Industry
Enrollment
90 participants

Conditions and interventions

Interventions

  • Leuprolide acetate Drug

Drug

Eligibility (public fields only)

Age range
65 Years and older
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 30, 2003
Primary completion
Feb 28, 2007
Completion
Feb 28, 2007
Last update posted
Dec 10, 2009

2003 – 2007

United States locations

U.S. sites
13
U.S. states
7
U.S. cities
13
Facility City State ZIP Site status
Margolin Brain Institute Fresno California 93720
Bay Area Research Institute Lafayette California 94549
Southwest Clinical Research Rancho Mirage California 92270
Geriatric and Adult Psychiatry LLC Hamden Connecticut 06518
Baumel-Eisner Neuromedical Institute Boca Raton Florida 33486
Brain Matters Research Delray Beach Florida 33445
Baumel-Eisner Neuromedical Institute Fort Lauderdale Florida 33321
Baumel-Eisner Neuromedical Institute Miami Beach Florida 33154
Meridien Research St. Petersburg Florida 33710
Boston University School of Medicine Boston Massachusetts 02118-2526
Medical University of South Carolina Charleston South Carolina 29406
Innovative Clinical Research Center Alexandria Virginia 22304
Middleton VA Wisconsin Alzheimer's Institute Madison Wisconsin 53705

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00076440, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 10, 2009 · Synced Apr 30, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00076440 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →